Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.0
4.5
Journals
Cancers
Journal Awards
Best Paper Award
share announcement

Best Paper Award

Dear Colleagues,

We are pleased to announce the “Cancers 2023 Best Paper Award” for research and review articles published in Cancers from 1 January 2023 to 31 December 2023. Two reviews and two research articles will receive an award each. The papers will be selected after a thorough evaluation by the journal Award Committee led by the Editor-in-Chief, Prof. Dr. Samuel C. Mok.

Eligibility for the Award:
– Papers published in Cancers from 1 January 2023 to 31 December 2023;
– Open to all career levels;
– Both regular and Special Issue submissions will be considered.

Selection Criteria:
The papers will be selected by the journal Award Committee according to the following criteria:
– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.

The Prize:
Two review awards and two research article awards will each receive CHF 500, an electronic certificate and a chance to publish a paper free of charge in Cancers before the end of June 2026 after peer review.

The winners will be announced on the journal website in June 2025.

Kind regards,
Cancers Editorial Office

 
Cancers Best Paper Award
 
Winner announcement: 30 June 2025

Eligibility and Requirements

– All papers published in Cancers will be eligible (Both regular and Special Issue submissions).
 
Past Winners
 
Year: 

Winner

14 pages, 900 KiB  
Article
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
by Timothy Crook, Robert Leonard, Kefah Mokbel, Alastair Thompson, Michael Michell, Raymond Page, Ashok Vaid, Ravi Mehrotra, Anantbhushan Ranade, Sewanti Limaye, Darshana Patil, Dadasaheb Akolkar, Vineet Datta, Pradip Fulmali, Sachin Apurwa, Stefan Schuster, Ajay Srinivasan and Rajan Datar
Cancers 2022, 14(14), 3341; https://doi.org/10.3390/cancers14143341 - 9 Jul 2022
18 pages, 2344 KiB  
Article
T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity
by Nadja Sailer, Ina Fetzer, Melanie Salvermoser, Monika Braun, Doris Brechtefeld, Christian Krendl, Christiane Geiger, Kathrin Mutze, Elfriede Noessner, Dolores J. Schendel, Maja Bürdek, Susanne Wilde and Daniel Sommermeyer
Cancers 2022, 14(8), 1998; https://doi.org/10.3390/cancers14081998 - 14 Apr 2022
27 pages, 12636 KiB  
Review
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
by Winnie M. C. van den Boogaard, Daphne S. J. Komninos and Wilbert P. Vermeij
Cancers 2022, 14(3), 627; https://doi.org/10.3390/cancers14030627 - 26 Jan 2022
29 pages, 1779 KiB  
Review
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
by Yang Zhou, Miao Li, Kuangyi Zhou, James Brown, Tasha Tsao, Xinjian Cen, Tiffany Husman, Aarushi Bajpai, Zachary Spencer Dunn and Lili Yang
Cancers 2022, 14(9), 2266; https://doi.org/10.3390/cancers14092266 - 1 May 2022

Award Committee

Dr. Samuel Mok Chairman
UT MD Anderson Cancer Center
Prof. Donat Kögel
Klinikum der Goethe-Universität Frankfurt
Dr. Nicola Amodio
Università Magna Graecia di Catanzaro

Winner

13 pages, 632 KiB  
Review
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer
by Alessandro Rizzo, Angela Dalia Ricci and Giovanni Brandi
Cancers 2021, 13(3), 558; https://doi.org/10.3390/cancers13030558 - 1 Feb 2021
24 pages, 790 KiB  
Review
STING Agonists as Cancer Therapeutics
by Afsaneh Amouzegar, Manoj Chelvanambi, Jessica N. Filderman, Walter J. Storkus and Jason J. Luke
Cancers 2021, 13(11), 2695; https://doi.org/10.3390/cancers13112695 - 30 May 2021
16 pages, 4842 KiB  
Article
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia
by Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. González-Rodríguez, Ángel R. Payer, Esther González-García, Alejandro López-Soto and Segundo Gonzalez
Cancers 2021, 13(9), 2112; https://doi.org/10.3390/cancers13092112 - 27 Apr 2021
15 pages, 934 KiB  
Article
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab
by Matteo Bauckneht, Carlo Genova, Giovanni Rossi, Erika Rijavec, Maria Giovanna Dal Bello, Giulia Ferrarazzo, Marco Tagliamento, Maria Isabella Donegani, Federica Biello, Silvia Chiola, Lodovica Zullo, Stefano Raffa, Francesco Lanfranchi, Giuseppe Cittadini, Cecilia Marini, Egesta Lopci, Gianmario Sambuceti, Francesco Grossi and Silvia Morbelli
Cancers 2021, 13(13), 3117; https://doi.org/10.3390/cancers13133117 - 22 Jun 2021

Award Committee

Dr. Samuel Mok Chairman
UT MD Anderson Cancer Center

Winner

38 pages, 5596 KiB  
Article
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
by Ranjit Manchanda, Li Sun, Shreeya Patel, Olivia Evans, Janneke Wilschut, Ana Carolina De Freitas Lopes, Faiza Gaba, Adam Brentnall, Stephen Duffy, Bin Cui, Patricia Coelho De Soarez, Zakir Husain, John Hopper, Zia Sadique, Asima Mukhopadhyay, Li Yang, Johannes Berkhof and Rosa Legood
Cancers 2020, 12(7), 1929; https://doi.org/10.3390/cancers12071929 - 17 Jul 2020
22 pages, 4459 KiB  
Article
Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer
by Aimy Sebastian, Nicholas R. Hum, Kelly A. Martin, Sean F. Gilmore, Ivana Peran, Stephen W. Byers, Elizabeth K. Wheeler, Matthew A. Coleman and Gabriela G. Loots
Cancers 2020, 12(5), 1307; https://doi.org/10.3390/cancers12051307 - 21 May 2020
24 pages, 1129 KiB  
Review
Ferroptosis in Cancer Cell Biology
by Christina M. Bebber, Fabienne Müller, Laura Prieto Clemente, Josephine Weber and Silvia von Karstedt
Cancers 2020, 12(1), 164; https://doi.org/10.3390/cancers12010164 - 9 Jan 2020
19 pages, 1446 KiB  
Review
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
by Raju K. Vaddepally, Prakash Kharel, Ramesh Pandey, Rohan Garje and Abhinav B. Chandra
Cancers 2020, 12(3), 738; https://doi.org/10.3390/cancers12030738 - 20 Mar 2020

Award Committee

Dr. Samuel Mok Chairman
UT MD Anderson Cancer Center

Winner

17 pages, 4148 KiB  
Article
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies
by Lynsey M. Whilding, Leena Halim, Benjamin Draper, Ana C. Parente-Pereira, Tomasz Zabinski, David Marc Davies and John Maher
Cancers 2019, 11(5), 674; https://doi.org/10.3390/cancers11050674 - 14 May 2019
11 pages, 1620 KiB  
Article
Blockade of Lactate Dehydrogenase-A (LDH-A) Improves Efficacy of Anti-Programmed Cell Death-1 (PD-1) Therapy in Melanoma
by Saeed Daneshmandi, Barbara Wegiel and Pankaj Seth
Cancers 2019, 11(4), 450; https://doi.org/10.3390/cancers11040450 - 29 Mar 2019
26 pages, 2915 KiB  
Review
Gut Microbiota and Cancer: From Pathogenesis to Therapy
by Silvia Vivarelli, Rossella Salemi, Saverio Candido, Luca Falzone, Maria Santagati, Stefania Stefani, Francesco Torino, Giuseppe Luigi Banna, Giuseppe Tonini and Massimo Libra
Cancers 2019, 11(1), 38; https://doi.org/10.3390/cancers11010038 - 3 Jan 2019
25 pages, 567 KiB  
Review
PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review
by Gabrielle Planes-Laine, Philippe Rochigneux, François Bertucci, Anne-Sophie Chrétien, Patrice Viens, Renaud Sabatier and Anthony Gonçalves
Cancers 2019, 11(7), 1033; https://doi.org/10.3390/cancers11071033 - 22 Jul 2019

Award Committee

Dr. Samuel Mok Chairman
UT MD Anderson Cancer Center
Back to TopTop